Blankenberg, S; McQueen, MJ; Smieja, M et al.
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.Circulation. Bd. 114. H. 3. 2006 S. 201-8
Hink, U; Münzel, T
COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?Circ Res. Bd. 98. H. 11. 2006 S. 1344-1346
Kleschyov, AL; Strand, S; Schmitt, S et al.
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Free Radical Bio Med. Bd. 40. H. 8. 2006 S. 1340-1348
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14
Wenzel, J; Lubos, E; Schnabel, R et al.
Evaluation of eNOS polymorphisms and the risk of future cardiovascular events in the AtheroGene studyEur Heart J. Bd. 27. 2006 S. 129 Suppl 1
Schnabel, R; Messow, CM; Lubos, E et al.
FLT-1 as an early diagnostic marker in acute coronary syndromes (Group Author(s): AtheroGene)Eur Heart J. Bd. 27. 2006 S. 152 Suppl 1
Schlitt, A; Blankenberg, S; Yan, D et al.
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.Nutr Metab Cardiovasc Dis. Bd. 3. 2006 S. 5
Morange, PE; Bickel, C; Nicaud, V et al.
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease.Arterioscler Thromb Vasc Biol. Bd. 26. 2006 S. 2793-2799
Blankenberg, S; Godefroy, T; Poirier, O et al.
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.Circ Res. Bd. 99. 2006 S. 102-108
Sinning, JM; Bickel, C; Messow, CM et al.
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.Eur Heart J. Bd. 27. H. 24. 2006 S. 2962-8
Baldus, S; Mullerleile, K; Chumley, P et al.
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.Free Radic Biol Med. Bd. 41. H. 8. 2006 S. 1282-1288
von Mach, MA; Habermehl, P; Zepp, F et al.
Intoxikationen mit Medikamenten im Kindesalter bei einem regionalen Giftinformationszentrum.Klin Padiatr. Bd. 218. H. 1. 2006 S. 31-3
August, M; Wingerter, O; Oelze, M et al.
Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits.Nitric Oxide. Bd. 15. H. 3. 2006 S. 241-251
Peetz, D; Schweigert, R; Jachmann, N et al.
Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.Clin Lab. Bd. 52. H. 11-12. 2006 S. 605-14
Mollnau, H; Wenzel, P; Oelze, M et al.
Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.BMC Cardiovasc Disord. Bd. 6. 2006 S. 44
Oelze, M; Warnholtz, A; Faulhaber, J et al.
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.Arterioscler Thromb Vasc Biol. Bd. 26. H. 8. 2006 S. 1753-9
Oelze, M; Daiber, A; Brandes, RP et al.
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.Hypertension. Bd. 48. H. 4. 2006 S. 677-84
Schinzel, H
Niedermolekulare Heparine in der IntensivmedizinS. Haas (Hrsg). Niedermolekulare Heparine. Springer 2006
Volz, S; Schinzel, H; Keune, N et al.
Niedermolekulares Heparin bei Fruhgeborenen mit hereditaren Risikofaktoren und venosen Thrombosen.Klin Padiatr. Bd. 218. H. 4. 2006 S. 226-9
Munzel, TF; Post, F
Pathogenese und Therapie des akuten Koronarsyndroms differenzieller Nutzen von GPIIb/IIIa-Rezeptorantagonisten bei Hochrisikopatienten.Dtsch Med Wochenschr. Bd. 131. H. 47 Suppl 7. 2006 S. S215-8
Vollmann, D; Erdogan, A; Himmrich, E et al.
Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.Europace. Bd. 8. H. 5. 2006 S. 371-6
Bierbach, B; Horstick, G; Berg, O et al.
Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.J Thromb Haemost. Bd. 95. H. 2. 2006 S. 354-61
Lubos, E; Schnabel, R; Rupprecht, HJ et al.
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene studyEur Heart J. Bd. 27. H. 2. 2006 S. 150-6
Fajadet, J; Wijns, W; Laarman, GJ et al.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.Circulation. Bd. 114. H. 8. 2006 S. 798-806
Lubos, E; Messow, CM; Schnabel, R et al.
Resistin, acute coronary syndrome and prognosis: Results from the AtheroGene studyCirculation. Bd. 114. H. 18. 2006 S. 422 Suppl S